FIELD: medicine.
SUBSTANCE: present invention relates to a method of producing a capsular form of an antimicrobial agent for treating gastrointestinal disorders, characterized by the fact that the bacteria recovered from sapropel are cultured on an agarized nutrient medium of the composition (g/l): peptic digest of animal tissue - 6.0, casein hydrolyzate - 4.0, yeast extract - 3.0, meat extract - 1.5, glucose - 1.0, agar-agar - 15.0, at temperature 37 °C to achieve a bacteria concentration of 2.0⋅106 CFU/ml, separation of biomass from nutrient medium by centrifugation, sublimation drying of supernatant and subsequent encapsulation of obtained dry residue into shell based on plant polysaccharides, wherein centrifugation is performed at 3900 rpm for 20 minutes, sublimation drying of supernatant - at vacuum 0.05 mbar and temperature -20 °C, and capsule used contains carrageenan, agar-agar, glycerine and water.
EFFECT: present invention provides developing a new method of producing a capsulated form of an antimicrobial preparation based on bacteria biomass isolated from sapropel for treating gastrointestinal diseases of a microbiological nature.
4 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MANUFACTURING ENCAPSULATED FORM OF A PROBIOTIC FOOD SUPPLEMENT | 2021 |
|
RU2795965C1 |
METHOD FOR OBTAINING A BACTERIOCIN-CONTAINING COMPOSITION | 2020 |
|
RU2773131C2 |
METHOD OF PRODUCING BACTERIAL PREPARATION WITH PROBIOTIC ACTIVITY | 2015 |
|
RU2605626C2 |
METABIOTIC COMPOSITION TO ENSURE COLONISATION RESISTANCE OF HUMAN INTESTINAL MICROBIOCENOSIS | 2015 |
|
RU2589818C1 |
STRAIN OF MEYEROZYMA (PICHIA) GUILLIERMONDII (VARIANTS), USED FOR PRODUCING PRE-, PRO-, AND AUTOPROBIOTIC AGENTS AND PRODUCTS FOR HUMANS AND ANIMALS, THERAPEUTIC AND PREVENTIVE AGENT BASED THEREON, AND METHOD FOR PRODUCTION THEREOF (VARIANTS) | 2021 |
|
RU2771136C1 |
PASTEURELLA MULTOCIDA "PM - B" BACTERIUM STRAIN FOR MANUFACTURE OF BIOPREPARATIONS FOR SPECIFIC PREVENTION OF PASTEURELLOSIS (HEMORRHAGIC SEPTICEMIA) IN CATTLE CAUSED BY SEROGROUP B PASTEURELLA | 2023 |
|
RU2818959C1 |
MEDICINAL AGENT, PHARMACEUTICAL COMPOSITION, HELICOBACTER PYLORI GROWTH INHIBITOR AND METHOD OF ANTIHELICOBACTERY THERAPY | 2007 |
|
RU2367458C1 |
ICE CREAM CONTAINING TREHALOSE, AGAROSE AND ERYTHRULOSE | 2012 |
|
RU2515381C1 |
METHOD FOR PRODUCING TRANSFORMED PLANT CELLS CONTAINING RECOMBINANT HUMAN ALKALINE PHOSPHATASE AND USING TRANSFORMED PLANT CELLS CONTAINING RECOMBINANT HUMAN ALKALINE PHOSPHATASE | 2018 |
|
RU2698397C2 |
METHOD FOR OBTAINING A BIOLOGICALLY ACTIVE ADDITIVE BASED ON WHEY AND PLANT EXTRACT | 2022 |
|
RU2792775C1 |
Authors
Dates
2021-02-24—Published
2020-03-03—Filed